A detailed history of New York Life Investment Management LLC transactions in Surmodics Inc stock. As of the latest transaction made, New York Life Investment Management LLC holds 18,368 shares of SRDX stock, worth $700,739. This represents 0.01% of its overall portfolio holdings.

Number of Shares
18,368
Previous 18,353 0.08%
Holding current value
$700,739
Previous $771,000 7.65%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$38.47 - $42.24 $577 - $633
15 Added 0.08%
18,368 $712,000
Q2 2024

Aug 05, 2024

BUY
$25.39 - $42.1 $465,982 - $772,661
18,353 New
18,353 $771,000
Q4 2022

Feb 10, 2023

BUY
$29.44 - $37.31 $41,628 - $52,756
1,414 Added 12.74%
12,516 $427,000
Q3 2022

Nov 10, 2022

BUY
$28.84 - $38.92 $23,475 - $31,680
814 Added 7.91%
11,102 $338,000
Q2 2022

Aug 12, 2022

BUY
$33.25 - $45.11 $342,076 - $464,091
10,288 New
10,288 $383,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $534M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track New York Life Investment Management LLC Portfolio

Follow New York Life Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on New York Life Investment Management LLC with notifications on news.